Bone-Directed Expression of Col1a1 Promoter-Driven Self-Inactivating Retroviral Vector in Bone Marrow Cells and Transgenic Mice
Open Access
- 30 April 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (4), 543-550
- https://doi.org/10.1006/mthe.2001.0293
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeted Overexpression of Insulin-Like Growth Factor I to Osteoblasts of Transgenic Mice: Increased Trabecular Bone Volume without Increased Osteoblast Proliferation1Endocrinology, 2000
- Amelioration of Retroviral Vector Silencing in Locus Control Region β-Globin-Transgenic Mice and Transduced F9 Embryonic CellsJournal of Virology, 1999
- Gene therapy - promises, problems and prospectsNature, 1997
- Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.Proceedings of the National Academy of Sciences, 1995
- Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantationBlood, 1994
- Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.Proceedings of the National Academy of Sciences, 1994
- Generation of a Transgenic Model for Retrovirus-Mediated Gene Therapy for Hepatocellular Carcinoma Is Thwarted by the Lack of Transgene ExpressionHuman Gene Therapy, 1993
- Histopathology Associated with Elevated Levels of Growth Hormone and Insulin-Like Growth Factor I in Transgenic Mice*Endocrinology, 1989
- Growth Enhancement of Transgenic Mice Expressing Human Insulin-Like Growth Factor I*Endocrinology, 1988
- Infectivity and methylation of retroviral genomes is correlated with expression in the animalCell, 1981